 Home > Analytical Chemistry > Analysis Reagents > Medroxyprogesterone for Sale > High Quality Medroxyprogesterone Powder CAS. 520-85-4

High Quality Medroxyprogesterone Powder CAS. 520-85-4 buy - large image1

High Quality Medroxyprogesterone Powder CAS. 520-85-4

Name: High Quality Medroxyprogesterone Powder CAS. 520-85-4
Brand: Custom
Price: 450 USD
Availability: InStock

2 Inquiries

Unit Price: Get Latest Price 

CAS No.:

520-85-4

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Durban

Brand:

Custom

Packaging:

As per customer requirement

Price valid (until):

2024-04-15

Contact Supplier

 Chat Now

Conex Chemicals PTY Ltd

Company Type:

Distributor

Location:

South Africa

Qualification:

Main Products:

Sodium Lauryl Ether Sulfate,Caustic Soda,Soda Ash,Citric Acid,Calcium Hypochlorite,Oxalic Acid

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

1. Medroxyprogesterone (CAS No. 520-85-4): The Hormonal Heroine in Women's Health

Embark on a journey through the multifaceted world of medroxyprogesterone, a synthetic progestin revered for its pivotal role in addressing a spectrum of women's health issues. From regulating menstrual cycles to managing menopausal symptoms, this description unveils medroxyprogesterone's therapeutic versatility and its profound impact on enhancing women's quality of life.

2. Medroxyprogesterone (520-85-4): Navigating Hormonal Harmony

Explore the intricate interplay of hormones with medroxyprogesterone, a pharmacological agent that exerts precise control over the menstrual cycle and reproductive function. Delve into its mechanisms of action, clinical applications, and therapeutic potentials, illuminating how medroxyprogesterone restores hormonal balance and empowers women to take charge of their health.

3. Medroxyprogesterone (CAS No. 520-85-4): Empowering Choices in Contraception

Discover the contraceptive prowess of medroxyprogesterone, a cornerstone in family planning that offers women a range of safe and effective birth control options. From injectable contraceptives to intrauterine devices, this description explores how medroxyprogesterone revolutionizes contraception by providing women with reliable and reversible methods tailored to their needs.

4. Medroxyprogesterone (520-85-4): Pioneering Menstrual Management

Navigate the landscape of menstrual disorders with medroxyprogesterone, a therapeutic ally in addressing irregular periods, heavy bleeding, and menstrual pain. This description delves into its mechanisms of action, clinical efficacy, and the transformative impact of medroxyprogesterone in restoring menstrual regularity and improving women's quality of life.

5. Medroxyprogesterone (CAS No. 520-85-4): A Lifeline in Menopausal Transition

Enter the realm of menopause with medroxyprogesterone, a trusted companion in alleviating menopausal symptoms and optimizing women's health during this transformative stage of life. From hot flashes to vaginal dryness, this description explores how medroxyprogesterone offers relief and support to women navigating the challenges of menopausal transition.

6. Medroxyprogesterone (520-85-4): Bridging the Gap in Hormone Replacement Therapy

Delve into the complexities of hormone replacement therapy with medroxyprogesterone, a key player in managing menopausal symptoms and reducing the risk of osteoporosis and cardiovascular disease. This description examines medroxyprogesterone's role in combination hormone therapy, its benefits, and potential risks, empowering women to make informed decisions about their health.

7. Medroxyprogesterone (CAS No. 520-85-4): Targeting Gynecological Disorders

Explore medroxyprogesterone's therapeutic arsenal in combating gynecological conditions such as endometriosis, uterine fibroids, and abnormal uterine bleeding. From its anti-inflammatory effects to its ability to regulate menstrual cycles, this description illuminates how medroxyprogesterone serves as a frontline treatment option in managing common gynecological disorders.

8. Medroxyprogesterone (520-85-4): Fostering Reproductive Health Across the Lifespan

Witness how medroxyprogesterone contributes to reproductive health at every stage of a woman's life, from adolescence to menopause and beyond. This description celebrates medroxyprogesterone's role in promoting fertility, managing reproductive disorders, and supporting overall reproductive well-being, empowering women to lead healthy and fulfilling lives.

9. Medroxyprogesterone (CAS No. 520-85-4): A Beacon of Hope in Endometrial Health

Discover medroxyprogesterone's pivotal role in managing endometrial health, from preventing endometrial hyperplasia to treating endometrial cancer. This description delves into its mechanisms of action, clinical efficacy, and the evolving landscape of medroxyprogesterone-based therapies in safeguarding women's reproductive health and preventing gynecological malignancies.

10. Medroxyprogesterone (520-85-4): Empowering Women's Health Through Science

Celebrate the transformative impact of medroxyprogesterone on women's health, as it continues to pave the way for innovative treatments and interventions that empower women to lead healthy, fulfilling lives. From contraception to menopause management, this description honors medroxyprogesterone's legacy as a beacon of hope and progress in women's healthcare.

Items	Specifications
1. Chemical Structure	Medroxyprogesterone is a synthetic derivative of the naturally occurring hormone progesterone. It has the chemical formula C22H30O2.
2. Pharmacological Class	It belongs to the class of drugs known as progestins or progestogens, which are synthetic analogs of progesterone and exert similar effects.
3. Mechanism of Action	Medroxyprogesterone works by binding to progesterone receptors in the body, exerting progestational effects such as thickening of cervical mucus, inhibition of ovulation, and support of pregnancy.
4. Indications	- Used for various gynecological and hormonal conditions, including contraception, menstrual disorders, endometriosis, and hormone replacement therapy (HRT).
	- Also prescribed to reduce the risk of endometrial hyperplasia (thickening of the uterine lining) in postmenopausal women receiving estrogen therapy.
5. Contraceptive Use	Medroxyprogesterone is employed as a component of certain contraceptive methods, including progestin-only pills, contraceptive injections (Depo-Provera), and contraceptive implants (Implanon).
6. Dosage Forms	Available in various dosage forms, including oral tablets, injectable suspensions, and intrauterine devices (IUDs), depending on the indication and route of administration.
7. Side Effects	Common side effects may include irregular menstrual bleeding, breast tenderness, mood changes, weight gain, and headaches.
8. Contraindications	Contraindicated in individuals with a history of breast cancer, liver disease, thromboembolic disorders, and undiagnosed vaginal bleeding.
9. Hormone Replacement Therapy	Medroxyprogesterone is often combined with estrogen in hormone replacement therapy (HRT) for postmenopausal women to reduce the risk of endometrial hyperplasia associated with estrogen therapy.
10. Long-Acting Injectable Form	The injectable suspension of medroxyprogesterone acetate (Depo-Provera) provides contraception for up to three months with a single injection.
11. Breastfeeding	While considered compatible with breastfeeding, caution is advised, and healthcare providers may recommend alternative methods of contraception for nursing mothers.
12. Pharmacokinetics	Medroxyprogesterone is metabolized in the liver and excreted primarily in the urine. Its half-life varies depending on the dosage form, ranging from hours to weeks.
13. Interactions	Interacts with certain medications, including some antibiotics, anticonvulsants, and herbal supplements, which may affect its efficacy or increase the risk of side effects.
14. Withdrawal Bleeding	Discontinuation of medroxyprogesterone therapy may lead to withdrawal bleeding or spotting, especially in women using it for contraception or hormonal disorders.
15. Medical Monitoring	Regular medical check-ups and monitoring of blood pressure, cholesterol levels, and bone density may be recommended for individuals on long-term medroxyprogesterone therapy.

Product Detail

Shop High Quality Medroxyprogesterone Powder CAS. 520-85-4-Detailed Image 1

Basic Info

Product Name:

Medroxyprogesterone

Other Name:

Pregn-4-ene-3,20-dione,17-hydroxy-6-methyl-,(6α)-;Pregn-4-ene-3,20-dione,17-hydroxy-6α-methyl-;Progesterone,17-hydroxy-6α-methyl-;(6α)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione;17-Hydroxy-6α-methylpregn-4-ene-3,20-dione;17α-Hydroxy-6α-methylprogesterone;Medroxyprogesteron;Medroxyprogesterone;6α-Methyl-17α-hydroxyprogesterone;U 8840;6α-Methyl-4-pregnen-17α-ol-3,20-dione;17-Hydroxy-6α-methylprogesterone;6α-Methyl-17-hydroxyprogesterone;6α-Methyl-17α-hydroxypregn-4-ene-3,20-dione;NSC 27408;6α-Methyl-17R-hydroxyprogesterone;Medoxyprogesterone;1050678-90-4

CAS No.:

520-85-4

Molecular Formula:

C22H32O3

InChIKeys:

InChIKey=FRQMUZJSZHZSGN-HBNHAYAOSA-N

Molecular Weight:

344.49

Exact Mass:

344.49

EC Number:

208-298-6

UNII:

HSU1C9YRES

NSC Number:

27408

DSSTox ID:

DTXSID0036508

NCI Thesaurus Code:

C629

Color/Form:

Crystals from chloroform

ATC Code:

G03AC06|G - Genito urinary system and sex hormones|L - Antineoplastic and immunomodulating agents

HScode:

29372390

Categories:

Analysis Reagents

Characteristics

PSA:

54.4

XLogP3:

3.50 (est)

Appearance:

Solid

Density:

1.1±0.1 g/cm3

Melting Point:

220-223.5 °C

Boiling Point:

488.0±45.0 °C at 760 mmHg

Flash Point:

263.0±25.2 °C

Refractive Index:

1.554

Water Solubility:

In water, 2.95 mg/L at 25 deg C (est)

Storage Conditions:

Refrigerator

Vapor Pressure:

1.93X10-10 mm Hg at 25 deg C (est)

Specific rotation:

D25 +75° (in chloroform)

Henrys Law Constant:

Henry's Law constant = 1.34X10-8 atm-cu m/mol at 25 °C (est)

Experimental Properties:

White to off-white, crystalline powder, odorless. Melting range 200-208 °C. Stable in air. Freely soluble in chlorform. /Medroxyprogesterone acetate/

See More Medroxyprogesterone Properties 

Hazard Identification

Classification of the substance or mixture

Reproductive toxicity, Category 2

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Warning
Hazard statement(s)	H361 Suspected of damaging fertility or the unborn child
Prevention	P203 Obtain, read and follow all safety instructions before use. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response	P318 IF exposed or concerned, get medical advice.
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Sterile medroxyprogesterone acetate suspensions should be stored at 20-25 deg C. The sterile injectable suspension containing medroxyprogesterone acetate in fixed combination with estradiol cypionate should be stored at 25 deg C, but may be exposed to temperatures ranging from 15-30deg C. Medroxyprogesterone acetate tablets should be stored in well-closed containers at 20-25 deg C.

See More Medroxyprogesterone Safety Data Sheet 

Seller Information

Business Type:
Distributor

Main Products:
Sodium Lauryl Ether Sulfate,Caustic Soda,Soda Ash,Citric Acid,Calcium Hypochlorite,Oxalic Acid

Location:
13 PROTEA PARK MILKWOOD STREET RANGEVIEW GAUTENG 1739

Payment Terms:
TT against copy of documents,TT against B/L draft before shipment

Average lead Time:
60

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2012

Inquiry History